Blood ApS: Financial statements 2024
CVR: 37650978
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Blood ApS (CVR 37650978) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,230 and a net result of DKK -7,047 compared with DKK -6,361 the year before. Equity in the 2024 report amounted to DKK 46,812. The solvency ratio was 93.1%.
- Gross Profit
- DKK -7,230
- Profit/Loss
- DKK -7,047
- Equity
- DKK 46,812
- Total Assets
- DKK 50,286
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -7 t. | -7 t. | 47 t. | 0 |
| 2023 | - | -9 t. | -6 t. | 54 t. | 0 |
| 2022 | - | -4 t. | -4 t. | 130 t. | 0 |
| 2021 | - | -2 t. | 246 t. | 248 t. | 0 |
| 2020 | - | -2 t. | 62 t. | 115 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Blood ApS has published its annual report for 2023. Gross profit came to DKK -8,618, and the net result was DKK -6,361.
About Blood ApS
Blood ApS is a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mikkel Nissen Jersin. The company is owned by Mikkel Nissen Jersin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,778 and a net result of DKK 142,452 compared with DKK -7,047 the year before. Equity in the 2025 report amounted to DKK 69,264.